EMEA-000713-PIP02-10-M04

  • Email
  • Help

Overview

Product details for Pixuvri
Invented namePixuvri
Active substance

pixantrone (dimaleate)

Decision numberP/0310/2016
PIP numberEMEA-000713-PIP02-10-M04
Pharmaceutical form(s)Powder for concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of non-Hodgkin lymphoma

Route(s) of administrationIntravenous use
PIP applicant

CTI Life Sciences Limited
United Kingdom
Tel. +44 (0)1494 596755
Fax +1 2062 846114
E-mail: JBianco@ctibiopharma.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information